
- /
- Supported exchanges
- / US
- / EXAS.NASDAQ
EXACT Sciences Corporation (EXAS NASDAQ) stock market data APIs
EXACT Sciences Corporation Financial Data Overview
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; OncoExTra Test for tumor profiling for patients with advanced, metastatic, refractory, relapsed, or recurrent cancer; and Riskguard Test, a hereditary cancer test to understand their inherited risk of cancer. Its pipeline focus on advancing screening and diagnostic products, including risk assessment, screening and prevention, early disease diagnosis, adjuvant and/or neoadjuvant disease treatment, metastatic disease treatment selection, and recurrence monitoring. The company has license agreements with MAYO Foundation for Medical Education and Research and Johns Hopkins University. Exact Sciences Corporation was incorporated in 1995 and is headquartered in Madison, Wisconsin.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get EXACT Sciences Corporation data using free add-ons & libraries
Get EXACT Sciences Corporation Fundamental Data
EXACT Sciences Corporation Fundamental data includes:
- Net Revenue: 2 759 M
- EBITDA: 29 761 K
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-02-19
- EPS/Forecast: -0.3327
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
EXACT Sciences Corporation News

1 Stock Under $50 to Target This Week and 2 to Turn Down
1 Stock Under $50 to Target This Week and 2 to Turn Down Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. B...


Exact Sciences Named 2025 Gallup Exceptional Workplace Award Winner
MADISON, Wis., March 12, 2025--(BUSINESS WIRE)--Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced it has received the 2025 Gallup Except...

3 Top Cancer Biotechs to Keep An Eye On in 2025
The landscape of cancer treatment is undergoing a transformative shift as there is a rising demand for targeted, less toxic cancer medicines. The cancer field has seen significant advancements with t...

Here’s What Led Artisan Mid Cap Fund to Trim Exact Sciences Corporation (EXAS)
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here. In the fourth quarter, the...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.